Clinical Trial Update: Investigation of Antipsoriatic Effects of UVB-induced Synthesis of 1alpha, 25-Dihydroxyvitamin D3 (1alpha, 25(OH)2D3, Calcitriol)in Keratinocytes of Psoriatic Skin, Using Cytochrom-P(CYP)Inhibitor Ketokonazol [Phase 2]

View source ↗

Summary

Phase 2 clinical trial exploring whether UVB-induced synthesis of calcitriol in psoriatic skin is influenced by the CYP inhibitor ketoconazole.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis Vulgaris

Drugs mentioned

• Calcitriol (calcitriol)
• Ketoconazole (Ketoconazole)

Snippet

Sponsor: Technische Universität Dresden | Conditions: Psoriasis Vulgaris | Phase 2 | Status: UNKNOWN